BIIB Biogen
- Official Name: BIOGEN INC.
- Headquarters: 225 Binney Street, CAMBRIDGE, MA, 02142 US
- CEO: Christopher Viehbacher
- Website: biogen.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1R | Won by 0.199 | (2.871) - (3.070) | ||
| 2025-07-18 | 1 | Lost by 6.858 | (5.609) - 1.249 | ||
| 2025-07-25 | 2 | Lost by 5.743 | 4.549 - 10.292 | ||
| 2025-07-29 | 2R | Lost by 2.129 | (1.652) - 0.477 | ||
| 2025-08-01 | 3 | Won by 6.740 | 0.635 - (6.105) | ||
| 2025-08-07 | 1R | Won by 0.254 | (1.225) - (1.479) | ||
| 2025-08-08 | 4 | Lost by 14.390 | 1.196 - 15.586 | ||
| 2025-08-15 | 5 | Lost by 1.151 | 5.113 - 6.264 | ||
| 2025-08-21 | 2R | Lost by 0.219 | 0.103 - 0.322 | ||
| 2025-08-22 | 6 | Lost by 0.017 | 1.483 - 1.500 | ||
| 2025-08-29 | 7 | Lost by 2.894 | (5.096) - (2.202) | ||
| 2025-09-05 | 8 | Won by 8.761 TOTW | 5.971 - (2.790) | ||
| 2025-09-12 | 9 | Won by 3.263 TOTW | 3.224 - (0.039) | ||
| 2025-09-19 | 10 | Lost by 4.358 | (1.568) - 2.790 | ||
| 2025-09-26 | 11 | Lost by 2.680 | (3.463) - (0.783) | ||
| 2025-10-03 | 12 | Won by 15.386 | 13.959 - (1.427) | ||
| 2025-10-10 | 13 | Lost by 4.077 | (8.310) - (4.233) | ||
| 2025-10-17 | 14 | Lost by 2.433 | (2.474) - (0.041) | ||
| 2025-10-24 | 15 | Lost by 2.567 | 5.084 - 7.651 |
Latest News
Yahoo - 2026-09-04
This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.
Ionis Pharmaceuticals wins regulatory clearance for its quarterly injection, Zanvastro, in Alexander disease. Analysts are focused elsewhere.
Yahoo - 2026-09-04
Exelixis (EXEL) Up 13.3% Since Last Earnings Report: Can It Continue?
Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo - 2026-09-04
Why Is Veeva Systems (VEEV) Winning Big In AI For Biopharma?
Veeva Systems (NYSE: VEEV) announced that Regeneron and Biogen have adopted its AI powered Vault CRM suite globally. The company also introduced Veeva...
Benzinga - 2026-09-04
Stoke, Biogen Report Lasting Seizure Reductions In Dravet Syndrome Study
Stoke Therapeutics, Inc. (NASDAQ:STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with R...
Yahoo - 2026-09-03
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
BEDFORD, Mass. & CAMBRIDGE, Mass., September 03, 2026--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring pro...
Benzinga - 2026-09-03
Piper Sandler Reiterates Overweight on Biogen, Raises Price Target to $245
Piper Sandler analyst David Amsellem reiterates Biogen (NASDAQ:BIIB) with a Overweight and raises the price target from $225 to $245.
Yahoo - 2026-09-03
Biogen (BIIB) Brings At Home Weekly Alzheimer’s Injection To U.S. Patients
Biogen (NasdaqGS: BIIB) and Eisai launched LEQEMBI IQLIK, a once-weekly subcutaneous injection for early Alzheimer's disease, now available in th...
Benzinga - 2026-09-03
Biogen And Eisai Win China Approval For At-Home Weekly Leqembi Alzheimer’s Treatment
Eisai Co., Ltd. and Biogen Inc. (NASDAQ:BIIB) announced today that the National Medical Products Administration (NMPA) of China has approved the subcu...
Yahoo - 2026-09-03
LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China
The First and Only Anti-Amyloid Therapy in China that Enables At-Home Administration for Alzheimer’s Disease, a Progressive Neurodegenerative Diseas...
Yahoo - 2026-09-02
Biogen (BIIB) Stock Could Be 48% Below Fair Value On New Dravet Data
Biogen stock has delivered a strong 57.2% return over the past year, yet investors are faced with a split verdict on value as a Discounted Cash Flow (...
Yahoo - 2026-09-02
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?
Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo - 2026-09-02
Biogen’s (BIIB) Immunology Bet Meets A Pricier Balance Sheet
On August 6, Biogen (NASDAQ:BIIB) completed its acquisition of RayThera, a privately held biotech developing small-molecule immunology therapies whose...
Yahoo - 2026-09-01
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
BEDFORD, Mass. & CAMBRIDGE, Mass., September 01, 2026--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring pro...
Benzinga - 2026-09-01
Stoke Therapeutics, Biogen Present Data On Zorevunersen As Treatment For Dravet Syndrome At 16th European Epilepsy Congress
Stoke Therapeutics, Inc. (NASDAQ:STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with R...
Yahoo - 2026-08-31
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
An Important Step Forward for Access to LEQEMBI® for Eligible Patients in CanadaTOKYO and CAMBRIDGE, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Eisai C...
Show more
Yahoo - 2026-08-30
Josh Brown Says ‘Take a Break From AI CapEx World,’ Highlights His 2 Top Healthcare Stock Picks
Yahoo - 2026-08-28
Why Is Biogen (BIIB) Up 6.5% Since Last Earnings Report?
Yahoo - 2026-08-27
Veeva Systems Inc (VEEV) (Q2 2027) Earnings Call Highlights: Record CRM Quarter and AI Momentum ...
Yahoo - 2026-08-26
Veeva Systems Q2 Earnings Call Highlights
SeekingAlpha - 2026-08-26
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade)
Yahoo - 2026-08-25
Veeva's Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings, Truist Says
Yahoo - 2026-08-25
3 Reasons to Sell BIIB and 1 Stock to Buy Instead
Yahoo - 2026-08-25
Veeva Vault CRM Selected by Biogen
Benzinga - 2026-08-25
RBC Capital Maintains Outperform on Biogen, Raises Price Target to $260
SeekingAlpha - 2026-08-24
Acadia Pharmaceuticals: Another Bite At The Alzheimer's Apple
Yahoo - 2026-08-24
LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
Yahoo - 2026-08-24
LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
Benzinga - 2026-08-24
Eisai And Biogen Announce Once Weekly Lecanemab-Irmb Subcutaneous Injection Is Now Available In U.S. For Initiation Therapy For Early Alzheimer’s Disease
SeekingAlpha - 2026-08-22
TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors
Yahoo - 2026-08-21
What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For Shareholders
Yahoo - 2026-08-20
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?
Yahoo - 2026-08-20
Is Wall Street Bullish or Bearish on Biogen Stock?
Yahoo - 2026-08-19
Real Parkinson’s Disease Hope from Jupiter Neurosciences
ChartMill - 2026-08-17
Biogen (NASDAQ:BIIB) Shows Strong Technical Breakout Setup With Perfect Trend Rating
Benzinga - 2026-08-13
Wolfe Research Upgrades Biogen to Outperform, Announces $300 Price Target
Yahoo - 2026-08-11
NovelMed Advances NM5072 for Multiple Ocular Disorders
Yahoo - 2026-08-07
Biogen (BIIB) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-07
DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum
Yahoo - 2026-08-06
Biogen Completes Acquisition of RayThera Inc.
SeekingAlpha - 2026-08-05
Stoke: 'Buy' On Zorevunersen NDA SCN1A DS And STK-002 Advancement
Yahoo - 2026-08-05
Biogen Stock: How To Find & Own America's Greatest Opportunities
Benzinga - 2026-08-04
Mizuho Maintains Outperform on Biogen, Raises Price Target to $241
Benzinga - 2026-08-04
Incyte Appoints Suketu (Suky) Upadhyay As Executive Vice President And CFO Effective May 4, 2026
Yahoo - 2026-08-03
Are These 5 Pharma Stocks Set to Surpass Q2 Earnings Forecasts?
Benzinga - 2026-08-03
Citigroup Maintains Neutral on Biogen, Raises Price Target to $215
Yahoo - 2026-08-03
4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
Yahoo - 2026-07-31
Is The Recent Pullback In Alnylam Stock An Opportunity Or A Trap?
Yahoo - 2026-07-30
IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 Outlook
Benzinga - 2026-07-30
UBS Maintains Buy on Biogen, Raises Price Target to $240
Benzinga - 2026-07-30
HC Wainwright & Co. Maintains Buy on Biogen, Raises Price Target to $251
Benzinga - 2026-07-30
Morgan Stanley Maintains Equal-Weight on Biogen, Raises Price Target to $231
Benzinga - 2026-07-30
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $240
Benzinga - 2026-07-30
Canaccord Genuity Maintains Buy on Biogen, Raises Price Target to $248
Benzinga - 2026-07-30
TD Cowen Maintains Buy on Biogen, Raises Price Target to $225
Benzinga - 2026-07-30
Wedbush Maintains Neutral on Biogen, Raises Price Target to $215
Yahoo - 2026-07-30
Biogen (BIIB) Is Up 5.8% After Earnings Compression Amid Revenue Growth – Is Profitability Peaking?
Yahoo - 2026-07-29
Why Biogen Stock Topped the Market Today
Yahoo - 2026-07-29
Biogen Inc (BIIB) Q2 2026 Earnings Call Highlights: Strong Growth in Core Pharmaceuticals and ...
Yahoo - 2026-07-29
Biogen Inc. Q2 2026 Earnings Call Summary
Yahoo - 2026-07-29
Drugmakers Climb On Q2 Reports, Even As One Misses Profit Views
Yahoo - 2026-07-29
Why Biogen Stock Is Resisting a Market Downturn After Earnings
SeekingAlpha - 2026-07-29
Biogen Inc. (BIIB) Q2 2026 Earnings Call Transcript
Yahoo - 2026-07-29
Biogen's Q2 Earnings Beat, New Drugs Drive Sales, 2026 Guidance Raised
Yahoo - 2026-07-29
Biogen Q2 Earnings Call Highlights
Yahoo - 2026-07-29
Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Benzinga - 2026-07-29
Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio
Yahoo - 2026-07-29
Biogen Beats Second-Quarter Expectations as Growth Portfolio Drives Revenue Higher
Yahoo - 2026-07-29
Biogen (NASDAQ:BIIB) Reports Upbeat Q2 CY2026
Yahoo - 2026-07-29
Why This Drugmaker’s Earnings Guidance Cut Doesn’t Tell the Full Story
Yahoo - 2026-07-29
Biogen Inc. (BIIB) Q2 Earnings and Revenues Top Estimates
SeekingAlpha - 2026-07-29
Biogen: The Turnaround Is Real Enough To Buy (Rating Upgrade)
Yahoo - 2026-07-29
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
Yahoo - 2026-07-29
Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
Yahoo - 2026-07-29
Biogen Raises Revenue Guidance as Growth Portfolio Outpaces Legacy Blockbuster Drugs
Benzinga - 2026-07-29
CORRECTION: Biogen Raises FY2026 Adj EPS Guidance from $15.25-$16.25 to $15.85-$16.85 vs $12.83 Est
SeekingAlpha - 2026-07-29
Biogen Inc. 2026 Q2 - Results - Earnings Call Presentation
Benzinga - 2026-07-29
Barclays Maintains Equal-Weight on Biogen, Raises Price Target to $200
Yahoo - 2026-07-28
Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of Earnings
Yahoo - 2026-07-28
The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals
Yahoo - 2026-07-27
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
SeekingAlpha - 2026-07-27
A Deeper Dive Into Design Therapeutics
Yahoo - 2026-07-24
Biogen Q2 Earnings: Can New Drugs Counter Falling MS Sales?
Yahoo - 2026-07-23
Will PTC Therapeutics (PTCT) Report Negative Earnings Next Week? What You Should Know
Yahoo - 2026-07-22
Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for
SeekingAlpha - 2026-07-21
Biogen And The Limitation Of The Tau Approach To Alzheimer's Disease
Yahoo - 2026-07-21
3 Profitable Stocks We Steer Clear Of
Benzinga - 2026-07-21
Guggenheim Maintains Buy on Biogen, Raises Price Target to $280
Benzinga - 2026-07-21
B of A Securities Maintains Neutral on Biogen, Lowers Price Target to $215
Yahoo - 2026-07-20
VERAXA Biotech Shows Regulatory Progress on Cancer Therapy Platform
SeekingAlpha - 2026-07-18
Stoke Therapeutics: Its Dravet Syndrome Lead Asset Enters The Last Stretch
Yahoo - 2026-07-16
Slate Medicines Appoints Mark W. Hahn to Board of Directors
Yahoo - 2026-07-16
Synapticure Launches Groundbreaking Ataxia Care Program, Expanding Access to Specialized Neurology Nationwide
Yahoo - 2026-07-15
3 Reasons to Avoid BIIB and 1 Stock to Buy Instead
Yahoo - 2026-07-15
Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data
Yahoo - 2026-07-15
Biogen Appoints Michael J. Parini as Chief Legal Officer
Yahoo - 2026-07-15
AAIC26: Biogen stock drops after unveiling tau-targeting ASO data
SeekingAlpha - 2026-07-15
Tau In The Clinic, Again
ChartMill - 2026-07-14
Discover which S&P500 stocks are making waves on Tuesday.
Yahoo - 2026-07-14
IBM, Goldman Sachs, SK Hynix, Micron, AMD, Apple, and More Stocks That Explain Today’s Market
Yahoo - 2026-07-14
Biogen Backs Alzheimer’s Tau Drug for Phase 3 Despite Trial Miss
SeekingAlpha - 2026-07-14
Biogen Inc. (BIIB) Presents at Alzheimer's Association International Conference (AAIC Meeting) 2026 - Slideshow
Yahoo - 2026-07-14
BIIB Stock On Track For Worst Day In 2 Years After RBC Questions If Alzheimer’s Drug Benefits Will Replicate In Further Study
Yahoo - 2026-07-14
Biogen stock falls 8% on Alzheimer's drug diranersen trial data
SeekingAlpha - 2026-07-14
Biogen Inc. (BIIB) Presents at Alzheimer's Association International Conference (AAIC Meeting) 2026 Transcript
ChartMill - 2026-07-14
These S&P500 stocks have an unusual volume in today's session
ChartMill - 2026-07-14
These S&P500 stocks are moving in today's session
Yahoo - 2026-07-14
Biogen Wins FDA Approval for Subcutaneous Starter Dose of Leqembi
Yahoo - 2026-07-14
Biogen Slumps As Alzheimer's Study Leaves 'More Questions Than Answers'
ChartMill - 2026-07-14
What's going on in today's session: S&P500 gap up and gap down stocks
Yahoo - 2026-07-14
Ionis Begins Dosing in Phase I/II Dravet Syndrome Study
Yahoo - 2026-07-14
Can Biogen Score Another Win In Alzheimer's Disease?
Yahoo - 2026-07-14
Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
Benzinga - 2026-07-14
Why Is Biogen Stock Falling Tuesday?
Yahoo - 2026-07-14
1 Mid-Cap Stock to Target This Week and 2 We Find Risky
Yahoo - 2026-07-13
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease
Yahoo - 2026-07-13
BIIB Stock Jumps 5% — Analysts Raise Price Targets After FDA Clears Alzheimer’s Treatment For At-Home Use
Yahoo - 2026-07-13
Stock Market Today, July 13: SK Hynix Tumbles 15% in South Korea, Leading Semiconductor Drop at Midday
Yahoo - 2026-07-13
Stock Market Today, July 13: Energy Stocks Cushion Dow as Tech Slides on Geopolitical Tensions
Benzinga - 2026-07-13
FDA Grants Approval For At-Home Starting Dose For Alzheimer's Treatment Leqembi
Yahoo - 2026-07-13
American Express, Biogen upgraded: Wall Street's top analyst calls
CNBC - 2026-07-13
Stocks making the biggest moves midday: Nio, Braiin, AppLovin, SpaceX, SK Hynix & more
Benzinga - 2026-07-13
This Biogen Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Benzinga - 2026-07-13
Truist Securities Upgrades Biogen to Buy, Raises Price Target to $235
Yahoo - 2026-07-10
Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up
Yahoo - 2026-07-10
The Long Climb Back For Ionis Stock
Yahoo - 2026-07-10
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Yahoo - 2026-07-09
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight
Yahoo - 2026-07-09
Biogen's Q2 2026 Earnings: What to Expect
Yahoo - 2026-07-09
Will New Board Appointment And mRNA Flu Progress Change Moderna's (MRNA) Pipeline Diversification Narrative?
Yahoo - 2026-07-08
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
Benzinga - 2026-07-08
Morgan Stanley Maintains Equal-Weight on Biogen, Lowers Price Target to $222
Benzinga - 2026-07-08
Congressional Trading Report: Rep. Maria Elvira Salazar Bought Over $50K In Brookfield Renewable Stock
Yahoo - 2026-07-08
Moderna Appoints Michael McDonnell to Board of Directors
Yahoo - 2026-07-07
IONS Completes Enrollment in Pivotal Cohort of Angelman Syndrome Study
Yahoo - 2026-07-07
Why Biogen (BIIB) is Poised to Beat Earnings Estimates Again
Benzinga - 2026-07-07
RBC Capital Maintains Outperform on Biogen, Raises Price Target to $242
Yahoo - 2026-07-07
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
Yahoo - 2026-07-06
3 Healthcare ETFs to Own in a Choppy Stock Market
Yahoo - 2026-07-05
Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right Now
Yahoo - 2026-07-04
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
Yahoo - 2026-07-02
BIIB Stock Ends 3% Higher — Why This Strategist Picks Biogen Over Other Biotech Peers
Yahoo - 2026-07-02
1 S&P 500 Stock with Promising Prospects and 2 We Question
Yahoo - 2026-07-02
Is Biogen (BIIB) Priced Near Fair Value After Its 57% Run?
Yahoo - 2026-07-01
Biogen (BIIB) To Share New Alzheimer’s Data At AAIC 2026
Benzinga - 2026-07-01
Biogen Expects $164M Q2 2026 And $290M-$320M Q3 2026 IPR&D And Milestone Charges, Impacting Earnings By $0.95 And $1.75–$1.95 Per Share, Respectively
Yahoo - 2026-07-01
Amgen or Biogen: Which Biotech Stock Appears Better Poised?
Yahoo - 2026-07-01
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
Yahoo - 2026-06-30
New Strong Sell Stocks for June 30th
Yahoo - 2026-06-29
Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
Yahoo - 2026-06-29
Biogen (BIIB) Moves 7.0% Higher: Will This Strength Last?
Yahoo - 2026-06-29
Biogen trims Apellis pipeline and R&D team after $5.6bn takeover
Benzinga - 2026-06-29
Biogen: Key Takeaways From Needham’s Meeting With Top Management
Yahoo - 2026-06-29
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
Benzinga - 2026-06-29
Needham Maintains Buy on Biogen, Raises Price Target to $256
Yahoo - 2026-06-26
Why Biogen (BIIB) Stock Is Up Today
Yahoo - 2026-06-26
Lilly, J&J and AbbVie Hit New Highs
CNBC - 2026-06-26
Stocks making the biggest moves midday: Moderna, ON Semiconductor, Rocket Lab, Eli Lilly, Sandisk & more
Yahoo - 2026-06-26
Can Biogen's New Drugs Revive Growth Amid Legacy Sales Slump?
Yahoo - 2026-06-25
Axtria Ignite 2026: 450+ Life Sciences Leaders Convene With a Contrarian Message -- Fix the Foundation Before You Scale AI
Yahoo - 2026-06-23
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
Yahoo - 2026-06-19
Biogen (BIIB) Stock Could Be 10.3% Undervalued on Its Pipeline Narrative
Yahoo - 2026-06-19
Biogen to acquire RayThera for up to $1bn
Yahoo - 2026-06-18
Sector Update: Healthcare Stocks Decline Thursday Afternoon
Yahoo - 2026-06-18
Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout
Yahoo - 2026-06-18
Biogen acquires RayThera in deal worth up to $1 billion
Benzinga - 2026-06-18
Biogen To Acquire RayThera For Up To $1 Billion, Expanding Immunology Pipeline
Benzinga - 2026-06-18
Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga - 2026-06-18
Morgan Stanley Maintains Equal-Weight on Biogen, Raises Price Target to $224
Yahoo - 2026-06-16
Acumen Nominates 2 Therapies to Treat Alzheimer’s Disease
Yahoo - 2026-06-16
Biogen Canada disappointed by outcome of pan-Canadian Pharmaceutical Alliance negotiations for SKYCLARYS™
Benzinga - 2026-06-15
Mizuho Maintains Outperform on Biogen, Lowers Price Target to $221
Yahoo - 2026-06-15
3 Overrated Stocks Walking a Fine Line
Benzinga - 2026-06-10
Congresswoman Who Bought No Stocks In 2025 Is Back With More 2026 Trades: Here's The Shopping List
Yahoo - 2026-06-10
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Find Risky
Yahoo - 2026-06-10
How Is Biogen’s Stock Performance Compared to Other Biotech Stocks?
Yahoo - 2026-06-09
EVERSANA Strengthens Commitment to Driving Market Access Growth with Addition of Industry Expert Jen Norton
Benzinga - 2026-06-09
This House of Representative Just Bought Up To $375K In Biogen Stock
Benzinga - 2026-06-08
Biogen's Base Is Declining — But 8 Pipeline Readouts Could Flip The Story
Benzinga - 2026-06-08
This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
Benzinga - 2026-06-08
Needham Upgrades Biogen to Buy, Announces $255 Price Target
Yahoo - 2026-06-05
Should Biogen’s (BIIB) New SMA Breakthrough and Lupus Data Prompt a Fresh Look From Investors?
Yahoo - 2026-06-05
A Look At Biogen (BIIB) Valuation After New Breakthrough SMA Nod And Positive Lupus Phase 3 Data
Yahoo - 2026-06-05
BIIB's Next-Gen SMA Therapy Salanersen Wins FDA's Breakthrough Tag
Yahoo - 2026-06-04
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?
Yahoo - 2026-06-04
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Benzinga - 2026-06-04
Biogen Says FDA Grants Salanersen Breakthrough Therapy Designation For Treatment Of Spinal Muscular Atrophy
Yahoo - 2026-06-04
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
Benzinga - 2026-06-04
UCB, Biogen Report New Lupus Drug Data at EULAR, Say Dapirolizumab Pegol Data Support Steroid Tapering
Yahoo - 2026-06-03
Ocugen's Gene-Agnostic Eye Therapies Could Reshape Late-Stage Care
Yahoo - 2026-06-03
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
Benzinga - 2026-06-03
Biogen Says Fourteen Abstracts Highlighting Data From Nephrology Portfolio, Including EMPAVELI And Investigational Felzartamab, Accepted For Presentation At 63rd ERA And 2026 ATC
Yahoo - 2026-06-03
Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors
Yahoo - 2026-06-02
Is COMPASS Pathways (CMPS) Quietly Recalibrating Its Commercialization Strategy With This Board Appointment?
Yahoo - 2026-06-01
Sobi to present new data on pegcetacoplan at ERA 2026
Yahoo - 2026-06-01
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
Benzinga - 2026-06-01
UCB and Biogen Report Late-Stage Lupus Trial Results for Experimental Drug
Yahoo - 2026-05-29
Why Is Biogen (BIIB) Up 3.8% Since Last Earnings Report?
SeekingAlpha - 2026-05-28
Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach
Benzinga - 2026-05-27
RBC Capital Maintains Outperform on Biogen, Raises Price Target to $227
SeekingAlpha - 2026-05-26
Leqembi Isn't Enough To Save Biogen Momentum (Rating Downgrade)
Yahoo - 2026-05-23
MarketBeat Week in Review – 05/18 - 05/22
Yahoo - 2026-05-22
Biogen Faces Trial Setbacks And Probes That Reframe Neuro Pipeline Risks
Yahoo - 2026-05-22
Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails
Yahoo - 2026-05-22
Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
Yahoo - 2026-05-22
Parkinson’s drug from Biogen, Denali comes up short
Yahoo - 2026-05-21
BIIB, DNLI Stocks Edge Lower After Hours: Parkinson’s Drug Misses Key Goals In Trial
Yahoo - 2026-05-21
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
Benzinga - 2026-05-21
Biogen And Denali Discontinue BIIB122 Development In Idiopathic Parkinson's Disease After Phase 2b LUMA Trial Misses Primary And Secondary Endpoints
Yahoo - 2026-05-19
Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout
Yahoo - 2026-05-19
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
Yahoo - 2026-05-19
How The Alector (ALEC) Investment Story Is Shifting With Tau Readthroughs And BBB Shuttle Focus
Yahoo - 2026-05-18
Biogen’s Apellis Deal And Alzheimer’s Trial Shift Focus Beyond Price
Finnhub - 2026-05-18
BIIB SHAREHOLDER INVESTIGATION: SueWallSt Investigates Biogen Inc. for Possible Securities Law Violations
Yahoo - 2026-05-17
Goldman Sachs sets new Biogen stock price target on bold Alzheimer's bet
Yahoo - 2026-05-15
BIIB Advances Alzheimer's Disease Drug Despite Study Missing Main Goal
Benzinga - 2026-05-15
Evercore ISI Group Reinstates Outperform on Biogen
Yahoo - 2026-05-15
Cisco upgraded, Doximity downgraded: Wall Street's top analyst calls
Yahoo - 2026-05-15